|
rs3025039
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The aim of this study was to evaluate the association between selected polymorphisms of the vascular endothelial growth factor gene (rs699947, rs144854329, rs833061, rs2010963, rs3025039) and the risk of prostate cancer development and progression.
|
31177128 |
2019 |
|
rs699947
|
|
|
0.020 |
GeneticVariation |
BEFREE |
And rs699947 polymorphism was also identified an increased risk of renal cell carcinoma (RCC) under dominant, recessive, homozygous, heterozygous and allelic contrast genetic models, while no association was observed in prostate cancer (PCa).
|
30195633 |
2018 |
|
rs3025039
|
|
|
0.020 |
GeneticVariation |
BEFREE |
VEGF rs3025039 polymorphism was also not associated with risk of prostate cancer (T versus C, OR = 1.03, 95% CI 0.91-1.16, P = 0.66; TT versus CC, OR = 1.82 95% CI 0.16-20.53, P = 0.63; TT versus CC/CT, OR = 2.00, 95% CI 0.18-22.41, P = 0.57; TT/CT versus CC, OR = 0.72, 95% CI 0.38-1.36, P = 0.31).
|
24353087 |
2014 |
|
rs699947
|
|
|
0.020 |
GeneticVariation |
BEFREE |
We evaluated the association between -2578 C/A (rs699947) VEGF polymorphism and PCa in Mexican subjects, to contribute to knowledge of VEGF role in genetic epidemiology of prostate cancer (PCa).
|
24240584 |
2013 |
|
rs1570360
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The results indicated that rs4764695/IGF1 and rs1570360/VEGF might play a key role in the development and progression of PCa.
|
24177231 |
2014 |
|
rs2010963
|
|
|
0.010 |
GeneticVariation |
BEFREE |
VEGF rs2010963 polymorphism was not associated with risk of prostate cancer under three models (C versus G, OR = 1.17, 95% CI 0.92-1.48, P = 0.20; CC versus GG, OR = 2.28, 95% CI 0.90-5.75, P = 0.08; CC versus GG/GC, OR = 1.57, 95% CI 0.67-3.68, P = 0.30).
|
24353087 |
2014 |
|
rs833061
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Overall, VEGF rs833061 polymorphism was not associated with risk of prostate cancer (T versus C, OR = 1.14, 95% CI 0.91-1.44, P = 0.26; TT versus CC, OR = 1.09, 95% CI 0.67-1.76, P = 0.74; TT versus
|
24353087 |
2014 |